logo
搜索
菜单

pharmacody的搜索结果

当前1/2页
排序: 本周浏览数
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components 01:14 min
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components
16.3: Modified-Release Drug Delivery Systems: Influencing Factors 01:20 min
16.3: Modified-Release Drug Delivery Systems: Influencing Factors
16.1: Drug Delivery Systems: Different Types 01:27 min
16.1: Drug Delivery Systems: Different Types
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions 01:15 min
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model 01:14 min
15.15: Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model 01:29 min
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model 01:15 min
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model 01:15 min
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model
15.10: Pharmacodynamic Models: Emax Drug–Concentration Effect Model 01:18 min
15.10: Pharmacodynamic Models: Emax Drug–Concentration Effect Model
15.9: Pharmacodynamic Models: Overview 01:27 min
15.9: Pharmacodynamic Models: Overview
15.8: Pharmacodynamic Responses: Different Types 01:03 min
15.8: Pharmacodynamic Responses: Different Types
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems 01:24 min
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship 01:23 min
15.4: Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect 01:26 min
15.1: Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu 01:29 min
14.3: Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment 01:08 min
13.18: Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
13.8: Pharmacodynamics in Geriatric Patients: Effects of Age 01:27 min
13.8: Pharmacodynamics in Geriatric Patients: Effects of Age
13.3: Drug Dosing: Geriatric Patients 01:15 min
13.3: Drug Dosing: Geriatric Patients
12.4: Dosage Regimen: Individualization 01:24 min
12.4: Dosage Regimen: Individualization
9.7: Measurement of Bioavailability: Pharmacodynamic Methods 01:20 min
9.7: Measurement of Bioavailability: Pharmacodynamic Methods
返回顶部